MannKind Corp., of Valencia, Calif., appointed Henry Nordhoff to its board.
MAP Pharmaceuticals Inc., of Mountain View, Calif., appointed Jerry Okikawa senior director, product development.
MaxCyte Inc., of Gaithersburg, Md., appointed Madhusudan Peshwa vice president, research and development.
Memory Pharmaceuticals Corp., of Montvale, N.J., appointed Tony Scullion president, and David Lowe to its board.
Millennium Pharmaceuticals Inc., of Cambridge, Mass., promoted Anna Protopapas to senior vice president, corporate development, and David Schenkein senior vice president, clinical research.
Momenta Pharmaceuticals Inc., of Cambridge, Mass., appointed Marsha Fanucci to its board.
Neurorecovery Inc., of Tuscaloosa, Ala., appointed Larry Buzbee vice president, sales; Thomas Hughes vice president, supply chain operations; and Michael Langdon vice president, finance.
Novagali Pharma, of Evry, France, appointed Florence Barouki-Binlich vice president development and medical affairs.
Ockham Development Group Inc., of Cary, N.C., appointed David Shoultz vice president of business development, Brian Kiley vice president of finance, and James Oliver president of the new Ockham Ventures division.